Treatment of Community-Acquired Pneumonia in Immunocompromised Adults: A Consensus Statement Regarding Initial Strategies.
expert_opinion · Level V
Where this comes from
- Record sourced from PubMed, PMID 32561442.
- Also identified by DOI 10.1016/j.chest.2020.05.598 and PMC identifier 7297164.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Community-acquired pneumonia (CAP) guidelines have improved the treatment and outcomes of patients with CAP, primarily by standardization of initial empirical therapy. But current society-published guidelines exclude immunocompromised patients. There is no consensus regarding the initial treatment of immunocompromised patients with suspected CAP. This consensus document was created by a multidisciplinary panel of 45 physicians with experience in the treatment of CAP in immunocompromised patients. The Delphi survey methodology was used to reach consensus. The panel focused on 21 questions addressing initial management strategies. The panel achieved consensus in defining the population, site of care, likely pathogens, microbiologic workup, general principles of empirical therapy, and empirical therapy for specific pathogens. This document offers general suggestions for the initial treatment of the immunocompromised patient who arrives at the hospital with pneumonia.
Medical subject headings
- Community-Acquired Infections
- Immunocompromised Host
- Patient Care Management
- Pneumonia